Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

Clinical trial NCT01626079 · UNKNOWN

Trial details

NCT number: NCT01626079
Sponsor: Abbott Medical Devices
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Mitral Regurgitation Mitral Valve Regurgitation Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects Heart Failure

Start date: 2012-08-01
Primary completion: 2019-03-01
Enrollment: 776

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.